Hepatitis C Virus Infection Unknown Status Phase 2 Trials for Sofosbuvir (DB08934)

IndicationStatusPhase
DBCOND0033268 (Hepatitis C Virus Infection)Unknown Status2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04111367Study of Seraprevir in Combination With Sofosbuvir in Chronic Genotype 2,3,6 Hepatitis C Virus Infection PatientsTreatment